Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.13 trillion and total revenue of $110.17 billion.
Market Cap
1.13T
Revenue
110.17B
Profits
-39.7B
PE Ratio
n/a
Profit Margin
-36.03%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.13B | -1.33% | 219,277 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.45B | -1.72% | 127,289 | 14.34B |
| 3 | ARGX | argenx SE | 49.22B | 0.18% | 88,391 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.42B | 1.90% | 193,280 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 34.61B | -0.42% | 17,105 | 5.34B |
| 6 | INSM | Insmed Incorporated | 33.86B | -1.71% | 242,975 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 27.71B | -0.54% | 445,948 | 2.38B |
| 8 | BNTX | BioNTech SE | 23.55B | 1.24% | 136,460 | 3.37B |
| 9 | MRNA | Moderna, Inc. | 20.74B | 1.99% | 1,408,809 | 1.94B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.15B | -1.12% | 992,557 | 13.31M |
| 11 | INCY | Incyte Corporation | 19.14B | -0.80% | 195,179 | 5.14B |
| 12 | RVMD | Revolution Medicines, Inc. | 19.05B | -0.10% | 336,152 | - |
| 13 | GMAB | Genmab A/S | 17.32B | -0.32% | 323,094 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 15.03B | 0.36% | 328,861 | - |
| 15 | ASND | Ascendis Pharma A/S | 14.67B | -1.77% | 141,279 | 845.52M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.48B | -1.11% | 185,567 | 502.08M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.47B | -1.22% | 237,697 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 11.95B | -2.01% | 279,735 | 4.27B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.82B | -1.71% | 31,560 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.49B | -2.55% | 513,601 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.58B | -2.31% | 288,510 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 9.77B | 0.76% | 362,387 | 5.37M |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.23B | -0.53% | 215,667 | 1.09B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 9.14B | -0.16% | 98,295 | 638.50M |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 8.91B | -0.14% | 54,800 | 7.46M |
| 26 | PCVX | Vaxcyte, Inc. | 8.79B | -1.02% | 161,180 | - |
| 27 | TECH | Bio-Techne Corporation | 8.68B | -0.14% | 126,030 | 1.22B |
| 28 | NUVL | Nuvalent, Inc. | 8.00B | -2.67% | 109,574 | - |
| 29 | HALO | Halozyme Therapeutics, Inc. | 7.96B | 0.18% | 135,439 | 1.40B |
| 30 | CYTK | Cytokinetics, Incorporated | 7.93B | -0.31% | 232,137 | 88.04M |
| 31 | KRYS | Krystal Biotech, Inc. | 7.61B | 0.13% | 33,877 | 389.13M |
| 32 | IBRX | ImmunityBio, Inc. | 7.56B | -2.14% | 4,550,466 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.02B | -1.54% | 73,849 | 39.21M |
| 34 | BLTE | Belite Bio, Inc | 6.88B | -3.43% | 59,447 | - |
| 35 | ACLX | Arcellx, Inc. | 6.74B | 0.01% | 230,939 | 22.29M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.46B | -2.78% | 75,946 | 46.02M |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.43B | 0.58% | 82,048 | - |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.14B | -0.10% | 465,220 | 15.00M |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.07B | 0.10% | 2,244,252 | - |
| 40 | COGT | Cogent Biosciences, Inc. | 5.92B | -1.66% | 150,704 | - |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 5.86B | -1.83% | 66,043 | 521.31M |
| 42 | CGON | CG Oncology, Inc. | 5.79B | 0.07% | 206,959 | 4.04M |
| 43 | PTCT | PTC Therapeutics, Inc. | 5.77B | -1.58% | 45,958 | 1.73B |
| 44 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.73B | -2.62% | 73,392 | 189.76M |
| 45 | CELC | Celcuity Inc. | 5.68B | -5.73% | 145,497 | - |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.63B | -0.45% | 130,434 | - |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 5.57B | -0.46% | 95,112 | 7.50M |
| 48 | ERAS | Erasca, Inc. | 5.30B | -1.79% | 536,651 | - |
| 49 | APLS | Apellis Pharmaceuticals, Inc. | 5.20B | 0.06% | 2,318,597 | 1.00B |
| 50 | CAI | Caris Life Sciences, Inc. | 5.17B | -4.69% | 519,405 | 812.03M |
| 51 | IMVT | Immunovant, Inc. | 5.17B | -0.97% | 174,745 | - |
| 52 | TGTX | TG Therapeutics, Inc. | 5.06B | -1.13% | 221,892 | 616.29M |
| 53 | CRSP | CRISPR Therapeutics AG | 4.90B | -1.20% | 157,233 | 3.51M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.75B | -2.16% | 120,439 | 2.04M |
| 55 | FOLD | Amicus Therapeutics, Inc. | 4.54B | -0.03% | 696,238 | 634.21M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.53B | 0.73% | 86,366 | 761.41M |
| 57 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.14B | -0.33% | 141,981 | 7.70M |
| 58 | SYRE | Spyre Therapeutics, Inc. | 4.10B | 0.71% | 88,038 | - |
| 59 | LGND | Ligand Pharmaceuticals Incorporated | 4.07B | -0.82% | 148,611 | 268.09M |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 4.03B | 0.03% | 114,786 | 22.50M |
| 61 | VKTX | Viking Therapeutics, Inc. | 4.03B | -0.46% | 556,508 | - |
| 62 | GPCR | Structure Therapeutics Inc. | 3.81B | -2.56% | 293,416 | - |
| 63 | ACAD | ACADIA Pharmaceuticals Inc. | 3.72B | -3.37% | 150,568 | 1.07B |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.54B | -1.55% | 104,149 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.51B | 6.73% | 222,063 | 803.79M |
| 66 | LEGN | Legend Biotech Corporation | 3.33B | -0.99% | 305,486 | 1.03B |
| 67 | DYN | Dyne Therapeutics, Inc. | 3.15B | -1.29% | 281,373 | - |
| 68 | TARS | Tarsus Pharmaceuticals, Inc. | 3.09B | 0.13% | 83,425 | 451.36M |
| 69 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.08B | -1.33% | 209,702 | 588.99M |
| 70 | ORKA | Oruka Therapeutics, Inc. | 3.02B | -4.23% | 199,187 | - |
| 71 | DNLI | Denali Therapeutics Inc. | 3.01B | -1.50% | 220,634 | - |
| 72 | VERA | Vera Therapeutics, Inc. | 2.99B | 2.25% | 203,907 | - |
| 73 | ALMS | Alumis Inc. | 2.95B | 1.07% | 100,160 | 24.05M |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 2.95B | -3.26% | 163,242 | 376.07M |
| 75 | TNGX | Tango Therapeutics, Inc. | 2.88B | -2.46% | 670,481 | 62.38M |
| 76 | RCUS | Arcus Biosciences, Inc. | 2.84B | -2.66% | 98,669 | 247.00M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.79B | -3.85% | 456,420 | 490.73M |
| 78 | SLNO | Soleno Therapeutics, Inc. | 2.72B | 0.04% | 799,081 | 190.41M |
| 79 | RLAY | Relay Therapeutics, Inc. | 2.70B | 0.87% | 980,904 | 15.36M |
| 80 | ELVN | Enliven Therapeutics, Inc. | 2.70B | -0.85% | 356,514 | - |
| 81 | IDYA | IDEAYA Biosciences, Inc. | 2.70B | -0.71% | 173,877 | 218.71M |
| 82 | KOD | Kodiak Sciences Inc. | 2.66B | 1.91% | 139,977 | - |
| 83 | BEAM | Beam Therapeutics Inc. | 2.61B | -0.27% | 349,633 | 139.74M |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.56B | -3.06% | 124,602 | 1.55M |
| 85 | IRON | Disc Medicine, Inc. | 2.53B | -1.58% | 32,647 | - |
| 86 | MANE | Veradermics, Incorporated | 2.47B | 10.45% | 124,168 | - |
| 87 | IMNM | Immunome, Inc. | 2.45B | -3.74% | 351,868 | 6.94M |
| 88 | ADMA | ADMA Biologics, Inc. | 2.33B | -1.41% | 778,066 | 510.17M |
| 89 | ZLAB | Zai Lab Limited | 2.32B | -0.68% | 94,598 | 460.16M |
| 90 | AAPG | Ascentage Pharma Group International | 2.31B | -2.65% | 135 | 82.08M |
| 91 | RARE | Ultragenyx Pharmaceutical Inc. | 2.28B | -2.66% | 191,001 | 673.00M |
| 92 | SRPT | Sarepta Therapeutics, Inc. | 2.26B | -3.28% | 290,244 | 2.20B |
| 93 | NKTR | Nektar Therapeutics | 2.22B | -0.44% | 100,167 | 55.23M |
| 94 | MLYS | Mineralys Therapeutics, Inc. | 2.22B | -0.88% | 217,087 | - |
| 95 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | -0.07% | 353,913 | 158.18M |
| 96 | DFTX | Definium Therapeutics, Inc. | 2.17B | 1.49% | 541,527 | - |
| 97 | SNDX | Syndax Pharmaceuticals, Inc. | 2.15B | -1.53% | 186,633 | 172.35M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.11B | -0.72% | 197,937 | 283.06M |
| 99 | STOK | Stoke Therapeutics, Inc. | 2.04B | -1.99% | 49,263 | 184.42M |
| 100 | ZYME | Zymeworks Inc. | 1.97B | -2.29% | 115,554 | 105.97M |
| 101 | ANAB | AnaptysBio, Inc. | 1.96B | -0.64% | 61,149 | 234.60M |
| 102 | ADPT | Adaptive Biotechnologies Corporation | 1.95B | -5.60% | 602,748 | 276.98M |
| 103 | MESO | Mesoblast Limited | 1.93B | 2.89% | 74,087 | 65.38M |
| 104 | OCUL | Ocular Therapeutix, Inc. | 1.93B | -4.62% | 762,087 | 51.95M |
| 105 | AGIO | Agios Pharmaceuticals, Inc. | 1.92B | -0.39% | 101,152 | 54.03M |
| 106 | TYRA | Tyra Biosciences, Inc. | 1.90B | -4.01% | 164,410 | - |
| 107 | GLPG | Galapagos NV | 1.88B | 0.42% | 42,704 | 1.31B |
| 108 | PVLA | Palvella Therapeutics, Inc. | 1.85B | -0.92% | 44,199 | - |
| 109 | INVA | Innoviva, Inc. | 1.79B | -0.21% | 140,115 | 411.33M |
| 110 | CAPR | Capricor Therapeutics, Inc. | 1.79B | -1.71% | 90,743 | 11.13M |
| 111 | RXRX | Recursion Pharmaceuticals, Inc. | 1.75B | -0.15% | 2,648,300 | 74.68M |
| 112 | PHVS | Pharvaris N.V. | 1.73B | -2.03% | 19,473 | - |
| 113 | VCEL | Vericel Corporation | 1.71B | 0.06% | 44,047 | 276.26M |
| 114 | TRVI | Trevi Therapeutics, Inc. | 1.71B | -0.15% | 140,883 | - |
| 115 | NRIX | Nurix Therapeutics, Inc. | 1.69B | 0.80% | 401,311 | 71.78M |
| 116 | HRMY | Harmony Biosciences Holdings, Inc. | 1.69B | 0.24% | 115,557 | 868.45M |
| 117 | SION | Sionna Therapeutics, Inc. | 1.68B | -4.14% | 53,274 | - |
| 118 | OCS | Oculis Holding AG | 1.64B | 1.73% | 8,478 | 1.51M |
| 119 | RAPP | Rapport Therapeutics, Inc. | 1.63B | -0.39% | 32,999 | - |
| 120 | IOVA | Iovance Biotherapeutics, Inc. | 1.60B | -2.87% | 11,730,301 | 263.50M |
| 121 | NTLA | Intellia Therapeutics, Inc. | 1.60B | -2.02% | 434,480 | 67.67M |
| 122 | IMCR | Immunocore Holdings plc | 1.59B | -1.57% | 53,521 | 400.02M |
| 123 | DMRA | Damora Therapeutics, Inc. | 1.57B | -2.59% | 127,191 | - |
| 124 | NUVB | Nuvation Bio Inc. | 1.56B | -1.73% | 540,691 | 62.90M |
| 125 | VRDN | Viridian Therapeutics, Inc. | 1.56B | -1.04% | 377,476 | 70.85M |
| 126 | VIR | Vir Biotechnology, Inc. | 1.53B | -2.34% | 244,738 | 68.56M |
| 127 | MBX | MBX Biosciences, Inc. | 1.53B | -2.25% | 79,309 | - |
| 128 | ARDX | Ardelyx, Inc. | 1.52B | 1.22% | 1,512,216 | 407.32M |
| 129 | PGEN | Precigen, Inc. | 1.48B | -2.34% | 723,865 | 9.68M |
| 130 | OLMA | Olema Pharmaceuticals, Inc. | 1.46B | 0.48% | 331,917 | - |
| 131 | NBTX | Nanobiotix S.A. | 1.46B | -3.07% | 9,234 | 38.27M |
| 132 | GENB | Generate Biomedicines, Inc. | 1.44B | -1.91% | 40,363 | 31.89M |
| 133 | GLUE | Monte Rosa Therapeutics, Inc. | 1.43B | -1.05% | 148,700 | 123.67M |
| 134 | SVRA | Savara Inc. | 1.42B | -4.26% | 227,305 | - |
| 135 | IMTX | Immatics N.V. | 1.41B | -1.50% | 49,844 | 56.67M |
| 136 | BCAX | Bicara Therapeutics Inc. | 1.41B | -2.18% | 89,907 | - |
| 137 | BHVN | Biohaven Ltd. | 1.39B | -1.81% | 169,495 | - |
| 138 | NVAX | Novavax, Inc. | 1.36B | -2.22% | 832,404 | 1.12B |
| 139 | WVE | Wave Life Sciences Ltd. | 1.35B | 0.14% | 345,953 | 42.73M |
| 140 | ATAI | AtaiBeckley Inc. | 1.34B | -0.41% | 714,219 | 4.09M |
| 141 | MAZE | Maze Therapeutics, Inc. | 1.34B | -3.48% | 140,067 | 2.50M |
| 142 | MLTX | MoonLake Immunotherapeutics | 1.33B | -4.35% | 289,525 | - |
| 143 | CRVS | Corvus Pharmaceuticals, Inc. | 1.29B | -2.17% | 102,872 | - |
| 144 | TSHA | Taysha Gene Therapies, Inc. | 1.28B | -3.78% | 494,805 | 9.77M |
| 145 | MPLT | MapLight Therapeutics, Inc. | 1.23B | -4.86% | 110,055 | - |
| 146 | ZBIO | Zenas BioPharma, Inc. | 1.23B | -2.80% | 67,746 | 10.00M |
| 147 | PHAR | Pharming Group N.V. | 1.20B | 2.41% | 821 | 376.13M |
| 148 | EYPT | EyePoint, Inc. | 1.17B | -1.62% | 178,331 | 31.37M |
| 149 | DBVT | DBV Technologies S.A. | 1.17B | -2.80% | 79,720 | 5.64M |
| 150 | AVBP | ArriVent BioPharma, Inc. | 1.16B | -3.60% | 92,190 | - |
| 151 | INBX | Inhibrx Biosciences, Inc. | 1.11B | 0.20% | 85,733 | 1.30M |
| 152 | GERN | Geron Corporation | 1.08B | -4.26% | 3,249,879 | 183.88M |
| 153 | ABCL | AbCellera Biologics Inc. | 1.07B | 2.62% | 1,286,552 | 75.13M |
| 154 | SEPN | Septerna, Inc. | 1.06B | -5.03% | 157,430 | 45.95M |
| 155 | XERS | Xeris Biopharma Holdings, Inc. | 1.02B | -1.25% | 212,788 | 291.85M |
| 156 | URGN | UroGen Pharma Ltd. | 1.01B | 1.51% | 252,385 | 109.79M |
| 157 | PHAT | Phathom Pharmaceuticals, Inc. | 1.01B | 0.87% | 358,617 | 175.11M |
| 158 | ORIC | ORIC Pharmaceuticals, Inc. | 1.01B | -2.79% | 396,593 | - |
| 159 | EVMN | Evommune, Inc. | 1.01B | -2.55% | 44,168 | 13.00M |
| 160 | KALV | KalVista Pharmaceuticals, Inc. | 999.86M | -2.16% | 126,731 | 73.62M |
| 161 | IVA | Inventiva S.A. | 979.97M | -1.45% | 163,403 | 9.31M |
| 162 | GHRS | GH Research PLC | 975.10M | 2.95% | 34,676 | - |
| 163 | QURE | uniQure N.V. | 951.07M | -6.69% | 339,912 | 16.10M |
| 164 | ANNX | Annexon, Inc. | 950.01M | -3.58% | 602,563 | - |
| 165 | AKTS | Aktis Oncology, Inc. | 931.95M | -4.58% | 76,592 | 6.50M |
| 166 | CTMX | CytomX Therapeutics, Inc. | 928.48M | 1.30% | 404,015 | 76.20M |
| 167 | CMPX | Compass Therapeutics, Inc. | 911.24M | -7.16% | 880,628 | 850.00K |
| 168 | XNCR | Xencor, Inc. | 899.87M | -2.08% | 70,041 | 125.58M |
| 169 | CGEM | Cullinan Therapeutics, Inc. | 885.50M | -3.81% | 62,940 | - |
| 170 | JANX | Janux Therapeutics, Inc. | 883.28M | -0.07% | 150,514 | 10.00M |
| 171 | SLS | SELLAS Life Sciences Group, Inc. | 880.85M | -2.87% | 1,324,920 | - |
| 172 | JBIO | Jade Biosciences, Inc. | 865.01M | -3.78% | 147,011 | - |
| 173 | FTRE | Fortrea Holdings Inc. | 859.27M | -2.03% | 101,198 | 2.72B |
| 174 | OMER | Omeros Corporation | 856.75M | -0.08% | 228,415 | - |
| 175 | VOR | Vor Biopharma Inc. | 842.86M | -0.29% | 127,235 | - |
| 176 | DRUG | Bright Minds Biosciences Inc. | 841.67M | -1.11% | 4,974 | - |
| 177 | TBPH | Theravance Biopharma, Inc. | 837.27M | -1.75% | 55,583 | 107.46M |
| 178 | ABUS | Arbutus Biopharma Corporation | 836.65M | -0.47% | 784,308 | 14.08M |
| 179 | SANA | Sana Biotechnology, Inc. | 829.96M | -0.32% | 546,144 | - |
| 180 | SPRY | ARS Pharmaceuticals, Inc. | 809.27M | -1.45% | 105,119 | 84.28M |
| 181 | MNKD | MannKind Corporation | 797.98M | 1.17% | 742,513 | 348.97M |
| 182 | SLDB | Solid Biosciences Inc. | 792.05M | -0.62% | 158,994 | - |
| 183 | RLMD | Relmada Therapeutics, Inc. | 789.81M | -1.05% | 461,162 | - |
| 184 | MRVI | Maravai LifeSciences Holdings, Inc. | 789.20M | -1.29% | 280,769 | 185.74M |
| 185 | KURA | Kura Oncology, Inc. | 764.05M | -2.26% | 226,990 | 67.48M |
| 186 | DSGN | Design Therapeutics, Inc. | 753.64M | -2.16% | 35,774 | - |
| 187 | MGTX | MeiraGTx Holdings plc | 746.86M | -1.82% | 95,030 | 81.39M |
| 188 | LXRX | Lexicon Pharmaceuticals, Inc. | 730.85M | -1.99% | 509,019 | 49.80M |
| 189 | TENX | Tenax Therapeutics, Inc. | 719.80M | -4.34% | 46,746 | - |
| 190 | SGP | SpyGlass Pharma, Inc. | 711.65M | 0.33% | 1,329 | - |
| 191 | ANRO | Alto Neuroscience, Inc. | 703.12M | -1.74% | 30,666 | - |
| 192 | ARVN | Arvinas, Inc. | 700.37M | -1.97% | 90,890 | 262.60M |
| 193 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 670.68M | -5.36% | 102,204 | - |
| 194 | ALLO | Allogene Therapeutics, Inc. | 670.39M | -5.50% | 1,497,656 | 22.00K |
| 195 | GYRE | Gyre Therapeutics, Inc. | 664.80M | 0.56% | 14,675 | 116.59M |
| 196 | DRTS | Alpha Tau Medical Ltd. | 635.43M | -1.77% | 29,727 | - |
| 197 | LBRX | LB Pharmaceuticals Inc | 630.45M | -5.21% | 149,507 | - |
| 198 | FBRX | Forte Biosciences, Inc. | 629.49M | -1.06% | 123,764 | - |
| 199 | OCGN | Ocugen, Inc. | 616.66M | -2.41% | 1,579,858 | 4.41M |
| 200 | CBIO | Crescent Biopharma, Inc. | 612.13M | -3.51% | 42,598 | 10.84M |
| 201 | PRME | Prime Medicine, Inc. | 591.45M | -4.84% | 480,185 | 4.63M |
| 202 | MDXG | MiMedx Group, Inc. | 582.38M | -2.73% | 114,491 | 418.63M |
| 203 | TECX | Tectonic Therapeutic, Inc. | 579.82M | -0.68% | 23,770 | - |
| 204 | CRMD | CorMedix Inc. | 579.44M | -0.41% | 167,973 | 311.71M |
| 205 | UPB | Upstream Bio, Inc. | 577.67M | 1.87% | 193,231 | 2.85M |
| 206 | PROK | ProKidney Corp. | 569.11M | -0.79% | 105,812 | 893.00K |
| 207 | ZVRA | Zevra Therapeutics, Inc. | 565.39M | -0.82% | 225,426 | 106.47M |
| 208 | PRTA | Prothena Corporation plc | 559.86M | -1.70% | 33,070 | 9.68M |
| 209 | KYTX | Kyverna Therapeutics, Inc. | 554.37M | -4.28% | 194,515 | - |
| 210 | ACRS | Aclaris Therapeutics, Inc. | 553.20M | -2.45% | 173,299 | 7.83M |
| 211 | RIGL | Rigel Pharmaceuticals, Inc. | 545.51M | -3.21% | 189,240 | 294.28M |
| 212 | ZURA | Zura Bio Limited | 540.82M | 1.79% | 48,126 | - |
| 213 | LYEL | Lyell Immunopharma, Inc. | 540.17M | -2.91% | 38,790 | 36.00K |
| 214 | AGMB | AgomAb Therapeutics NV | 540.00M | 8.52% | 35,020 | - |
| 215 | VALN | Valneva SE | 534.59M | 1.30% | 3,826 | 205.07M |
| 216 | LRMR | Larimar Therapeutics, Inc. | 515.78M | -2.46% | 323,402 | - |
| 217 | FULC | Fulcrum Therapeutics, Inc. | 506.16M | -3.92% | 190,588 | 80.00M |
| 218 | STTK | Shattuck Labs, Inc. | 500.23M | -5.54% | 81,063 | 1.00M |
| 219 | TRDA | Entrada Therapeutics, Inc. | 496.80M | -1.78% | 51,726 | 25.42M |
| 220 | FDMT | 4D Molecular Therapeutics, Inc. | 491.12M | -2.24% | 269,906 | 85.21M |
| 221 | IMMX | Immix Biopharma, Inc. | 489.83M | -5.23% | 149,538 | - |
| 222 | CTNM | Contineum Therapeutics, Inc. | 485.37M | 1.33% | 45,445 | - |
| 223 | IVVD | Invivyd, Inc. | 483.59M | -3.93% | 6,490,582 | 53.43M |
| 224 | VSTM | Verastem, Inc. | 481.34M | -1.97% | 289,883 | 30.91M |
| 225 | EIKN | Eikon Therapeutics, Inc. | 479.94M | -1.61% | 183,620 | - |
| 226 | ENGN | enGene Holdings Inc. | 477.63M | -1.93% | 23,636 | - |
| 227 | ADCT | ADC Therapeutics SA | 475.15M | -0.53% | 130,546 | 81.36M |
| 228 | ASMB | Assembly Biosciences, Inc. | 468.90M | -0.97% | 42,699 | 72.30M |
| 229 | AVIR | Atea Pharmaceuticals, Inc. | 460.50M | -1.03% | 35,168 | - |
| 230 | VTVT | vTv Therapeutics Inc. | 459.15M | -0.80% | 12,649 | 17.00K |
| 231 | LXEO | Lexeo Therapeutics, Inc. | 457.12M | -4.04% | 162,390 | - |
| 232 | RGNX | REGENXBIO Inc. | 454.75M | -1.67% | 75,671 | 170.44M |
| 233 | ZNTL | Zentalis Pharmaceuticals, Inc. | 452.54M | 44.34% | 25,352,855 | 26.87M |
| 234 | ABSI | Absci Corporation | 448.35M | -0.68% | 773,399 | 2.80M |
| 235 | YDES | YD Bio Limited | 435.98M | 7.27% | 1,202 | 510.36K |
| 236 | EPRX | Eupraxia Pharmaceuticals Inc. | 433.75M | -0.71% | 22,616 | - |
| 237 | AURA | Aura Biosciences, Inc. | 433.02M | -0.44% | 28,175 | - |
| 238 | XOMA | XOMA Royalty Corporation | 432.42M | -1.28% | 13,195 | 52.15M |
| 239 | ALT | Altimmune, Inc. | 428.70M | -2.51% | 367,550 | 41.00K |
| 240 | ANL | Adlai Nortye Ltd. | 424.72M | -4.08% | 53,979 | -1.35M |
| 241 | VNDA | Vanda Pharmaceuticals Inc. | 421.44M | -2.73% | 250,377 | 216.11M |
| 242 | STRO | Sutro Biopharma, Inc. | 421.14M | -5.01% | 39,311 | 102.48M |
| 243 | ENTA | Enanta Pharmaceuticals, Inc. | 413.67M | 2.19% | 59,380 | 66.98M |
| 244 | AUTL | Autolus Therapeutics plc | 407.20M | 4.08% | 674,196 | 75.39M |
| 245 | CLYM | Climb Bio, Inc. | 404.12M | 5.09% | 263,595 | - |
| 246 | IPSC | Century Therapeutics, Inc. | 403.48M | -0.66% | 128,264 | 109.16M |
| 247 | ARMP | Armata Pharmaceuticals, Inc. | 403.33M | -4.51% | 5,445 | 4.90M |
| 248 | IRD | Opus Genetics, Inc. | 401.99M | 2.73% | 305,380 | 14.20M |
| 249 | BNTC | Benitec Biopharma Inc. | 396.67M | 5.18% | 33,321 | - |
| 250 | REPL | Replimune Group, Inc. | 394.70M | -19.12% | 2,940,251 | - |
| 251 | PBYI | Puma Biotechnology, Inc. | 392.79M | -1.02% | 46,989 | 228.37M |
| 252 | RCKT | Rocket Pharmaceuticals, Inc. | 389.02M | -0.97% | 504,279 | - |
| 253 | RZLT | Rezolute, Inc. | 388.48M | 2.47% | 536,310 | - |
| 254 | PRTC | PureTech Health plc | 387.51M | 1.55% | 2,518 | 6.39M |
| 255 | NMRA | Neumora Therapeutics, Inc. | 385.02M | 1.68% | 185,517 | - |
| 256 | MNPR | Monopar Therapeutics Inc. | 381.32M | -1.62% | 84,125 | - |
| 257 | DNA | Ginkgo Bioworks Holdings, Inc. | 379.51M | 1.40% | 239,547 | 170.16M |
| 258 | LCTX | Lineage Cell Therapeutics, Inc. | 372.39M | 0.34% | 107,720 | 14.56M |
| 259 | XFOR | X4 Pharmaceuticals, Inc. | 371.86M | 0.49% | 29,094 | 35.11M |
| 260 | OVID | Ovid Therapeutics Inc. | 370.57M | -2.43% | 1,009,514 | 7.25M |
| 261 | PRLD | Prelude Therapeutics Incorporated | 367.28M | 1.14% | 70,129 | 12.14M |
| 262 | IMRX | Immuneering Corporation | 367.23M | 0.35% | 182,170 | - |
| 263 | NAUT | Nautilus Biotechnology, Inc. | 367.04M | -4.61% | 134,220 | - |
| 264 | GLSI | Greenwich LifeSciences, Inc. | 363.06M | 1.49% | 27,450 | - |
| 265 | NAGE | Niagen Bioscience, Inc. | 356.70M | -0.78% | 52,457 | 129.42M |
| 266 | CADL | Candel Therapeutics, Inc. | 351.59M | - | 165,783 | - |
| 267 | CABA | Cabaletta Bio, Inc. | 345.10M | -2.21% | 462,177 | - |
| 268 | BCYC | Bicycle Therapeutics plc | 345.05M | -0.40% | 236,145 | 72.59M |
| 269 | NGEN | NervGen Pharma Corp. | 334.24M | -1.90% | 102,283 | - |
| 270 | ACIU | AC Immune SA | 333.32M | -1.18% | 148,810 | 4.51M |
| 271 | NGNE | Neurogene Inc. | 326.90M | -1.78% | 13,498 | 925.00K |
| 272 | DMAC | DiaMedica Therapeutics Inc. | 322.76M | -3.07% | 46,212 | - |
| 273 | SRZN | Surrozen, Inc. | 320.48M | 1.64% | 35,966 | 3.48M |
| 274 | PALI | Palisade Bio, Inc. | 310.57M | -6.31% | 903,226 | - |
| 275 | AVTX | Avalo Therapeutics, Inc. | 306.96M | -5.21% | 261,780 | 59.00K |
| 276 | IKT | Inhibikase Therapeutics, Inc. | 291.42M | 1.18% | 365,596 | 1.00 |
| 277 | LENZ | LENZ Therapeutics, Inc. | 287.21M | -1.40% | 116,914 | 19.09M |
| 278 | ABEO | Abeona Therapeutics Inc. | 283.53M | -2.93% | 811,558 | 5.82M |
| 279 | EDIT | Editas Medicine, Inc. | 278.94M | -1.38% | 547,536 | 40.52M |
| 280 | NBP | NovaBridge Biosciences | 277.85M | -0.82% | 91,583 | - |
| 281 | AVXL | Anavex Life Sciences Corp. | 277.55M | -1.80% | 218,189 | - |
| 282 | TARA | Protara Therapeutics, Inc. | 275.83M | -3.95% | 187,905 | - |
| 283 | ALEC | Alector, Inc. | 271.49M | 2.50% | 158,001 | 21.05M |
| 284 | FHTX | Foghorn Therapeutics Inc. | 268.55M | -4.49% | 33,111 | 30.91M |
| 285 | SABS | SAB Biotherapeutics, Inc. | 264.94M | -1.57% | 53,886 | 114.70K |
| 286 | SLN | Silence Therapeutics plc | 260.73M | -4.83% | 228,871 | 559.00K |
| 287 | PLYX | Polaryx Therapeutics, Inc. | 260.39M | -4.51% | 71,493 | - |
| 288 | ADAG | Adagene Inc. | 260.33M | 2.47% | 109,387 | 7.67M |
| 289 | HELP | Cybin Inc. | 259.69M | -0.95% | 224,515 | - |
| 290 | MIST | Milestone Pharmaceuticals Inc. | 258.79M | 4.98% | 2,025,983 | 1.55M |
| 291 | CLLS | Cellectis S.A. | 257.82M | 5.71% | 5,381 | 79.59M |
| 292 | NERV | Minerva Neurosciences, Inc. | 254.89M | -2.16% | 78,654 | - |
| 293 | CCCC | C4 Therapeutics, Inc. | 251.75M | -8.83% | 1,615,712 | 35.95M |
| 294 | CHRS | Coherus Oncology, Inc. | 251.07M | 1.52% | 139,314 | 42.17M |
| 295 | OBIO | Orchestra BioMed Holdings, Inc. | 249.30M | 0.71% | 22,680 | 33.48M |
| 296 | CGEN | Compugen Ltd. | 243.95M | 4.03% | 360,750 | 72.76M |
| 297 | CAMP | Camp4 Therapeutics Corporation | 240.65M | 3.23% | 4,600 | 3.50M |
| 298 | SLGL | Sol-Gel Technologies Ltd. | 240.60M | 2.19% | 21,086 | 19.39M |
| 299 | CNTX | Context Therapeutics Inc. | 238.89M | 0.39% | 148,368 | - |
| 300 | ARCT | Arcturus Therapeutics Holdings Inc. | 237.33M | 1.58% | 124,430 | 82.03M |
| 301 | ELDN | Eledon Pharmaceuticals, Inc. | 237.01M | 0.65% | 209,006 | - |
| 302 | MGNX | MacroGenics, Inc. | 235.16M | 7.56% | 978,756 | 149.50M |
| 303 | KROS | Keros Therapeutics, Inc. | 234.05M | -4.96% | 70,343 | 244.06M |
| 304 | MDWD | MediWound Ltd. | 228.83M | 0.20% | 10,878 | 16.96M |
| 305 | VYGR | Voyager Therapeutics, Inc. | 225.29M | -4.55% | 217,794 | 40.37M |
| 306 | ENLV | Enlivex Ltd. | 222.19M | -1.43% | 57,992 | - |
| 307 | OABI | OmniAb, Inc. | 217.90M | 0.33% | 34,261 | 18.67M |
| 308 | NVCT | Nuvectis Pharma, Inc. | 216.70M | 0.25% | 4,749 | - |
| 309 | ALXO | ALX Oncology Holdings Inc. | 213.86M | -4.41% | 328,194 | - |
| 310 | FENC | Fennec Pharmaceuticals Inc. | 206.85M | -6.25% | 53,658 | 44.64M |
| 311 | CDXS | Codexis, Inc. | 206.27M | -5.42% | 421,394 | 70.39M |
| 312 | PRQR | ProQR Therapeutics N.V. | 199.13M | -4.55% | 135,339 | 19.19M |
| 313 | CRBU | Caribou Biosciences, Inc. | 186.51M | -1.53% | 183,436 | 11.16M |
| 314 | KRRO | Korro Bio, Inc. | 186.48M | -1.15% | 22,239 | 6.39M |
| 315 | ELTX | Elicio Therapeutics, Inc. | 184.88M | -2.33% | 9,843 | - |
| 316 | PLX | Protalix BioTherapeutics, Inc. | 184.11M | 0.22% | 105,991 | 52.74M |
| 317 | TNXP | Tonix Pharmaceuticals Holding Corp. | 183.39M | -0.69% | 102,818 | 13.11M |
| 318 | KPTI | Karyopharm Therapeutics Inc. | 183.28M | -0.37% | 107,420 | 146.07M |
| 319 | MENS | Jyong Biotech Ltd. | 183.02M | -11.19% | 67,924 | - |
| 320 | ACHV | Achieve Life Sciences, Inc. | 181.02M | 2.41% | 128,202 | - |
| 321 | ABOS | Acumen Pharmaceuticals, Inc. | 180.17M | -0.60% | 55,147 | - |
| 322 | DTIL | Precision BioSciences, Inc. | 178.04M | 4.39% | 76,904 | 34.26M |
| 323 | CNTN | Canton Strategic Holdings, Inc. | 177.90M | -7.65% | 759,302 | - |
| 324 | SGMT | Sagimet Biosciences Inc. | 174.98M | -4.79% | 156,795 | - |
| 325 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 173.29M | -5.33% | 67,657 | - |
| 326 | ARTV | Artiva Biotherapeutics, Inc. | 170.55M | 1.47% | 31,889 | 251.00K |
| 327 | UNCY | Unicycive Therapeutics, Inc. | 167.83M | - | 78,046 | - |
| 328 | WHWK | Whitehawk Therapeutics, Inc. | 163.30M | -2.54% | 9,618 | 7.15M |
| 329 | CNTB | Connect Biopharma Holdings Limited | 161.37M | 2.70% | 25,726 | 64.00K |
| 330 | MOLN | Molecular Partners AG | 160.98M | 0.44% | 11 | 856.30K |
| 331 | AGEN | Agenus Inc. | 160.12M | -6.29% | 668,419 | 114.20M |
| 332 | HRTX | Heron Therapeutics, Inc. | 158.88M | 2.84% | 594,333 | 154.90M |
| 333 | TLSA | Tiziana Life Sciences Ltd | 158.25M | -1.59% | 18,079 | - |
| 334 | RNAC | Cartesian Therapeutics, Inc. | 157.73M | -3.72% | 18,525 | 2.80M |
| 335 | GALT | Galectin Therapeutics Inc. | 156.34M | -2.26% | 42,092 | - |
| 336 | IMUX | Immunic, Inc. | 153.95M | -8.53% | 1,090,801 | - |
| 337 | NKTX | Nkarta, Inc. | 153.63M | -7.91% | 340,024 | - |
| 338 | SPRO | Spero Therapeutics, Inc. | 153.41M | -4.68% | 244,049 | 66.80M |
| 339 | TNYA | Tenaya Therapeutics, Inc. | 152.22M | -5.20% | 1,942,403 | - |
| 340 | BDTX | Black Diamond Therapeutics, Inc. | 148.38M | 0.39% | 419,669 | 70.00M |
| 341 | FATE | Fate Therapeutics, Inc. | 143.59M | -2.76% | 403,088 | 6.65M |
| 342 | HUMA | Humacyte, Inc. | 142.65M | 5.85% | 1,164,142 | 2.04M |
| 343 | HURA | TuHURA Biosciences, Inc. | 141.78M | 13.78% | 927,580 | - |
| 344 | ORMP | Oramed Pharmaceuticals Inc. | 141.56M | -0.57% | 4,535 | 2.00M |
| 345 | KLRS | Kalaris Therapeutics, Inc. | 137.11M | -1.48% | 13,627 | - |
| 346 | ACOG | Alpha Cognition Inc. | 132.60M | -4.55% | 4,459 | 10.22M |
| 347 | IPHA | Innate Pharma S.A. | 128.37M | -2.07% | 20,276 | 10.57M |
| 348 | BMEA | Biomea Fusion, Inc. | 127.25M | -4.86% | 289,461 | - |
| 349 | ONCY | Oncolytics Biotech Inc. | 123.10M | 1.92% | 730,097 | - |
| 350 | EQ | Equillium, Inc. | 120.13M | -0.52% | 46,733 | 4.39M |
| 351 | PMN | ProMIS Neurosciences, Inc. | 112.10M | - | 18,507 | - |
| 352 | SGMO | Sangamo Therapeutics, Inc. | 111.85M | 3.09% | 1,678,153 | 39.55M |
| 353 | ANTX | AN2 Therapeutics, Inc. | 111.06M | 1.31% | 155,173 | - |
| 354 | GNLX | Genelux Corporation | 110.66M | -2.58% | 56,594 | 8.00K |
| 355 | PEPG | PepGen Inc. | 109.55M | -1.55% | 256,730 | - |
| 356 | CRDF | Cardiff Oncology, Inc. | 109.04M | -4.49% | 203,702 | 593.00K |
| 357 | NTHI | NeOnc Technologies Holdings, Inc. | 106.89M | -12.30% | 30,770 | 39.99K |
| 358 | KZIA | Kazia Therapeutics Limited | 105.24M | 1.21% | 11,628 | 1.27M |
| 359 | ALDX | Aldeyra Therapeutics, Inc. | 105.02M | 9.75% | 750,494 | - |
| 360 | CBUS | Cibus, Inc. | 104.36M | 8.73% | 556,458 | 3.64M |
| 361 | PYXS | Pyxis Oncology, Inc. | 104.30M | 3.11% | 329,935 | 13.86M |
| 362 | EXOZ | eXoZymes, Inc. | 103.87M | 7.46% | 9,635 | -700.00 |
| 363 | TTRX | Turn Therapeutics Inc. | 100.53M | -3.85% | 39,423 | - |
| 364 | COYA | Coya Therapeutics, Inc. | 99.22M | -6.62% | 46,576 | 7.95M |
| 365 | GOSS | Gossamer Bio, Inc. | 98.43M | 12.86% | 4,819,192 | 48.47M |
| 366 | SEER | Seer, Inc. | 95.07M | -0.30% | 10,021 | 16.58M |
| 367 | VRCA | Verrica Pharmaceuticals Inc. | 91.56M | -8.58% | 45,073 | 35.58M |
| 368 | LONA | LeonaBio, Inc. | 91.49M | 2.10% | 24,328 | - |
| 369 | ANIX | Anixa Biosciences, Inc. | 89.52M | -2.55% | 123,286 | - |
| 370 | SPRB | Spruce Biosciences, Inc. | 89.03M | -1.70% | 31,827 | 697.00K |
| 371 | VANI | Vivani Medical, Inc. | 88.46M | 0.48% | 4,914 | - |
| 372 | AARD | Aardvark Therapeutics, Inc. | 86.17M | 1.28% | 10,357 | - |
| 373 | INO | Inovio Pharmaceuticals, Inc. | 85.67M | - | 559,079 | 65.34K |
| 374 | PYPD | PolyPid Ltd. | 83.58M | 0.23% | 12,063 | - |
| 375 | PLRX | Pliant Therapeutics, Inc. | 82.97M | -0.74% | 27,857 | - |
| 376 | FLNA | Filana Therapeutics, Inc. | 82.61M | -0.58% | 44,569 | - |
| 377 | MCRB | Seres Therapeutics, Inc. | 82.44M | -1.26% | 34,554 | 789.00K |
| 378 | ESLA | Estrella Immunopharma, Inc. | 81.92M | 3.78% | 67,330 | - |
| 379 | OKYO | OKYO Pharma Limited | 81.87M | -1.27% | 65,970 | - |
| 380 | CGTX | Cognition Therapeutics, Inc. | 80.25M | 4.41% | 196,949 | - |
| 381 | CSBR | Champions Oncology, Inc. | 79.29M | -0.70% | 6,566 | 57.95M |
| 382 | PTHS | Pelthos Therapeutics Inc. | 77.68M | 2.52% | 214 | 16.80M |
| 383 | NRXS | NeurAxis, Inc. | 77.64M | -4.28% | 78,783 | 3.57M |
| 384 | COEP | Coeptis Therapeutics Holdings, Inc. | 76.86M | -2.14% | 4,582 | 1.36M |
| 385 | ATYR | aTyr Pharma, Inc. | 76.56M | 4.11% | 212,161 | 190.00K |
| 386 | FBIO | Fortress Biotech, Inc. | 76.32M | -1.25% | 140,155 | 63.26M |
| 387 | GANX | Gain Therapeutics, Inc. | 75.61M | -2.72% | 103,481 | - |
| 388 | MAIA | MAIA Biotechnology, Inc. | 75.23M | 3.33% | 223,193 | - |
| 389 | IBIO | iBio, Inc. | 74.96M | -1.36% | 163,235 | 300.00K |
| 390 | IFRX | InflaRx N.V. | 74.46M | - | 60,828 | 34.44K |
| 391 | BYSI | BeyondSpring Inc. | 74.43M | 2.26% | 1,259 | 1.88M |
| 392 | MNOV | MediciNova, Inc. | 73.83M | 5.63% | 17,162 | 409.66K |
| 393 | NRXP | NRx Pharmaceuticals, Inc. | 73.50M | -1.55% | 158,571 | 1.23M |
| 394 | RANI | Rani Therapeutics Holdings, Inc. | 72.89M | -6.29% | 478,549 | 1.63M |
| 395 | ACET | Adicet Bio, Inc. | 72.50M | -1.68% | 12,668 | - |
| 396 | GUTS | Fractyl Health, Inc. | 72.30M | -3.00% | 89,370 | 3.00K |
| 397 | QTTB | Q32 Bio Inc. | 71.68M | -0.41% | 56,249 | 53.74M |
| 398 | IBO | Impact BioMedical Inc. | 71.59M | -6.48% | 41,095 | 32.00K |
| 399 | XBIT | XBiotech Inc. | 71.04M | - | 11,796 | - |
| 400 | PMVP | PMV Pharmaceuticals, Inc. | 69.59M | -1.88% | 125,124 | - |
| 401 | ATHE | Alterity Therapeutics Limited | 69.21M | -0.13% | 222 | 4.43M |
| 402 | CING | Cingulate Inc. | 67.91M | -2.01% | 117,269 | - |
| 403 | DWTX | Dogwood Therapeutics, Inc. | 66.80M | 1.01% | 20,727 | - |
| 404 | ICCC | ImmuCell Corporation | 64.59M | -0.70% | 5,853 | 27.64M |
| 405 | PDSB | PDS Biotechnology Corporation | 60.84M | 1.87% | 496,506 | - |
| 406 | ACRV | Acrivon Therapeutics, Inc. | 60.83M | 1.29% | 158,909 | - |
| 407 | TCRX | TScan Therapeutics, Inc. | 58.61M | -2.83% | 378,996 | 10.33M |
| 408 | TIL | Instil Bio, Inc. | 56.70M | -1.36% | 9,438 | - |
| 409 | INKT | MiNK Therapeutics, Inc. | 56.22M | -1.29% | 7,049 | - |
| 410 | OKUR | OnKure Therapeutics, Inc. | 56.20M | -3.97% | 29,841 | - |
| 411 | OSTX | OS Therapies Incorporated | 55.51M | -2.19% | 116,031 | - |
| 412 | HYFT | MindWalk Holdings Corp. | 55.13M | -0.89% | 49,806 | 20.70M |
| 413 | KZR | Kezar Life Sciences, Inc. | 54.73M | 1.02% | 7,727 | - |
| 414 | GRCE | Grace Therapeutics, Inc. | 54.31M | -3.04% | 118,418 | - |
| 415 | IMA | ImageneBio, Inc. | 53.69M | 1.05% | 3,612 | 800.00K |
| 416 | EDSA | Edesa Biotech, Inc. | 53.14M | 1.01% | 64,608 | - |
| 417 | ENTX | Entera Bio Ltd. | 52.68M | -1.74% | 3,452 | 42.00K |
| 418 | RADX | Radiopharm Theranostics Limited | 52.63M | -2.47% | 14,053 | 10.86M |
| 419 | MGX | Metagenomi Therapeutics, Inc. | 51.92M | -0.72% | 12,050 | 25.21M |
| 420 | MREO | Mereo BioPharma Group plc | 51.06M | -0.03% | 369,962 | 500.00K |
| 421 | XLO | Xilio Therapeutics, Inc. | 49.73M | 0.47% | 1,634 | 43.77M |
| 422 | ALGS | Aligos Therapeutics, Inc. | 49.07M | -0.13% | 17,807 | 2.19M |
| 423 | NTRB | Nutriband Inc. | 47.29M | 1.04% | 2,197 | 2.28M |
| 424 | LSTA | Lisata Therapeutics, Inc. | 45.21M | 0.10% | 1,223 | 170.00K |
| 425 | ANVS | Annovis Bio, Inc. | 44.94M | -2.16% | 1,257,498 | - |
| 426 | RNXT | RenovoRx, Inc. | 44.60M | 1.19% | 362,021 | 1.12M |
| 427 | RLYB | Rallybio Corporation | 43.59M | 0.37% | 12,175 | 858.00K |
| 428 | LITS | Lite Strategy, Inc. | 43.27M | 1.71% | 97,909 | - |
| 429 | ACTU | Actuate Therapeutics, Inc. | 42.85M | -4.39% | 10,790 | - |
| 430 | HOWL | Werewolf Therapeutics, Inc. | 42.81M | -1.94% | 40,664 | 1.14M |
| 431 | IMMP | Immutep Limited | 42.73M | -2.24% | 249,115 | 5.28M |
| 432 | TELO | Telomir Pharmaceuticals, Inc. | 42.63M | -1.59% | 31,099 | - |
| 433 | RNTX | Rein Therapeutics Inc. | 41.78M | -2.61% | 7,893 | - |
| 434 | ATOS | Atossa Therapeutics, Inc. | 41.59M | -3.01% | 6,155 | - |
| 435 | HYPD | Hyperion DeFi, Inc. | 41.47M | 11.31% | 99,379 | 813.46K |
| 436 | SNSE | Sensei Biotherapeutics, Inc. | 39.93M | -2.42% | 9,272 | - |
| 437 | CELU | Celularity Inc. | 39.22M | - | 1,041 | 40.58M |
| 438 | ATRA | Atara Biotherapeutics, Inc. | 39.01M | -1.24% | 15,752 | 120.77M |
| 439 | VERU | Veru Inc. | 38.68M | -0.82% | 6,793 | 16.89M |
| 440 | NXTC | NextCure, Inc. | 38.67M | -3.12% | 20,312 | - |
| 441 | CUE | Cue Biopharma, Inc. | 38.53M | 34.69% | 8,318,304 | 27.47M |
| 442 | CRVO | CervoMed Inc. | 37.31M | - | 6,737 | 4.01M |
| 443 | PSTV | Plus Therapeutics, Inc. | 35.75M | 32.91% | 515,991 | 5.21M |
| 444 | ATNM | Actinium Pharmaceuticals, Inc. | 34.38M | -3.27% | 26,013 | 90.00K |
| 445 | ABVC | ABVC BioPharma, Inc. | 34.35M | -2.80% | 19,405 | 797.92K |
| 446 | PLUR | Pluri Inc. | 33.37M | -2.06% | 493 | 1.34M |
| 447 | EVAX | Evaxion A/S | 33.36M | -2.68% | 62,591 | 7.53M |
| 448 | LIXT | Lixte Biotechnology Holdings, Inc. | 33.34M | -1.03% | 4,850 | - |
| 449 | CVM | CEL-SCI Corporation | 33.26M | -3.97% | 7,210 | - |
| 450 | INMB | INmune Bio Inc. | 33.23M | -2.34% | 66,917 | 50.00K |
| 451 | DYAI | Dyadic International, Inc. | 33.14M | 3.85% | 159 | 3.09M |
| 452 | LGVN | Longeveron Inc. | 32.94M | 1.35% | 348,079 | 1.20M |
| 453 | BCTX | BriaCell Therapeutics Corp. | 32.94M | -4.19% | 73,207 | - |
| 454 | APLM | Apollomics, Inc. | 32.42M | 1.68% | 2,829 | 6.93M |
| 455 | PTN | Palatin Technologies, Inc. | 31.99M | 0.71% | 1,400 | 8.96M |
| 456 | PASG | Passage Bio, Inc. | 31.44M | -12.42% | 22,813 | - |
| 457 | KYNB | Kyntra Bio, Inc. | 28.93M | -0.56% | 462 | 6.44M |
| 458 | IGC | IGC Pharma, Inc. | 28.07M | -2.66% | 158,120 | 1.11M |
| 459 | MRKR | Marker Therapeutics, Inc. | 27.93M | -4.29% | 58,684 | 3.55M |
| 460 | TVRD | Tvardi Therapeutics, Inc. | 27.77M | - | 4,296 | - |
| 461 | SNTI | Senti Biosciences, Inc. | 27.21M | 0.99% | 16,718 | 22.00K |
| 462 | DARE | Daré Bioscience, Inc. | 27.15M | 0.81% | 36,483 | 1.03M |
| 463 | XCUR | Exicure, Inc. | 26.39M | 0.98% | 1,032 | 500.00K |
| 464 | TPST | Tempest Therapeutics, Inc. | 26.11M | 15.19% | 234,331 | - |
| 465 | BOLD | Boundless Bio, Inc. | 25.66M | 0.44% | 29,235 | - |
| 466 | NRSN | NeuroSense Therapeutics Ltd. | 25.63M | -0.70% | 9,588 | - |
| 467 | NEUP | Neuphoria Therapeutics Inc. | 24.91M | -2.12% | 2,623 | 14.99M |
| 468 | TVGN | Tevogen Bio Holdings Inc. | 24.44M | 0.17% | 10,455 | - |
| 469 | SKYE | Skye Bioscience, Inc. | 24.04M | -0.79% | 25,850 | - |
| 470 | OTLK | Outlook Therapeutics, Inc. | 23.91M | 2.88% | 515,117 | 205.70K |
| 471 | SER | Serina Therapeutics, Inc. | 23.77M | -3.50% | 33,445 | 130.00K |
| 472 | VTGN | Vistagen Therapeutics, Inc. | 22.88M | 3.90% | 151,237 | 789.00K |
| 473 | BRNS | Barinthus Biotherapeutics plc | 22.47M | - | 7,029 | 14.97M |
| 474 | LEXX | Lexaria Bioscience Corp. | 22.40M | -0.54% | 43,146 | 522.00K |
| 475 | NNVC | NanoViricides, Inc. | 22.03M | -3.77% | 32,737 | - |
| 476 | AEON | AEON Biopharma, Inc. | 21.84M | 3.97% | 7,706 | - |
| 477 | LTRN | Lantern Pharma Inc. | 21.75M | 3.74% | 150,059 | - |
| 478 | JSPR | Jasper Therapeutics, Inc. | 21.62M | -6.23% | 394,524 | - |
| 479 | VYNE | VYNE Therapeutics Inc. | 20.29M | -0.59% | 8,762 | 570.00K |
| 480 | CRIS | Curis, Inc. | 20.27M | -0.59% | 405,143 | 9.44M |
| 481 | QNTM | Quantum BioPharma Ltd. | 18.97M | - | 49,249 | - |
| 482 | ALLR | Allarity Therapeutics, Inc. | 18.82M | 3.46% | 42,885 | 320.00K |
| 483 | COCP | Cocrystal Pharma, Inc. | 18.20M | -7.69% | 188,147 | - |
| 484 | CTXR | Citius Pharmaceuticals, Inc. | 18.11M | -3.97% | 99,222 | 3.94M |
| 485 | PLRZ | Polyrizon Ltd. | 17.78M | 1.95% | 20,482 | - |
| 486 | KTTA | Pasithea Therapeutics Corp. | 17.28M | -3.76% | 169,540 | - |
| 487 | OSRH | OSR Holdings, Inc. | 17.22M | 1.82% | 293,579 | 2.91M |
| 488 | GNTA | Genenta Science S.p.A. | 16.04M | 0.13% | 7,287 | - |
| 489 | HIND | Vyome Holdings, Inc. | 15.97M | -1.09% | 6,586 | 319.71K |
| 490 | LPCN | Lipocine Inc. | 15.48M | 1.44% | 416,710 | 1.98M |
| 491 | ICU | SeaStar Medical Holding Corporation | 15.06M | -7.14% | 75,352 | 1.23M |
| 492 | INAB | IN8bio, Inc. | 14.48M | 2.80% | 1,247 | - |
| 493 | PHIO | Phio Pharmaceuticals Corp. | 14.46M | -0.40% | 47,506 | - |
| 494 | JUNS | Jupiter Neurosciences, Inc. | 14.15M | 1.75% | 13,956 | 21.80K |
| 495 | INTS | Intensity Therapeutics, Inc. | 13.64M | -4.11% | 1,890 | - |
| 496 | MBRX | Moleculin Biotech, Inc. | 13.49M | -0.86% | 10,584 | - |
| 497 | BCDA | BioCardia, Inc. | 13.02M | 1.71% | 1,639 | 3.00K |
| 498 | CYCN | Cyclerion Therapeutics, Inc. | 12.62M | -5.54% | 169,551 | 2.07M |
| 499 | TRAW | Traws Pharma, Inc. | 12.23M | 2.00% | 12,375 | 2.85M |
| 500 | CVKD | Cadrenal Therapeutics, Inc. | 12.22M | -1.91% | 1,254 | - |